Copper (Cu) is an essential micronutrient for brain development, as its deficiency impairs brain development by disturbing brain energy metabolism via mitochondrial dysfunction.
Copper (Cu) is an essential micronutrient for brain development, as its deficiency impairs brain development by disturbing brain energy metabolism via mitochondrial dysfunction. 1) Thus, the brain contains high levels of Cu, 2) which increases during the course of postnatal development. However, Cu can also be toxic, as its redox reactivity may lead to cell damage through oxidative modifications of protein, lipids, and nucleic acids due to the activities of reactive oxygen species (ROS).
3) Cu also promotes ROS formation, by catalyzing the reaction between superoxide anion and hydrogen peroxide, thus producing hydroxyl radicals. 4) Furthermore, Cu can bind directly to free thiols of cysteines, leading to oxidation, and cross-links between proteins, thereby impairing enzymes and structural proteins. 5) Therefore, cellular Cu homeostasis is tightly regulated to allow sufficient Cu for normal cellular functions, while preventing excess Cu accumulation beyond normal cellular levels.
During development of the vertebrate nervous system, 50% or more of neurons normally die soon after they form synaptic connections with their target cells. 6) Under normal physiological conditions, cell death with apoptotic characteristics helps to remove excess or unwanted cells. In recent studies, Cu caused concentration-and time-dependent cell death with apoptotic characteristics in cultured cerebellar granule neuronal, 7) and neuroblastoma 8) cells. In those studies, Cu potently induced ROS, and quickly increased the intracellular concentration of Ca, though slightly. Furthermore, an increase in Ca is known to activate neuronal nitric oxide synthase (nNOS). NOS activity is high in the postnatal brain, with the peak level preceding the period of maximal synaptogenesis.
9) It was also reported that NO may react with superoxide anion to form peroxynitrite, which is a highly reactive and toxic agent, and cause neurotoxicity. 9, 10) Taken together, ROS and NO may act as mediators of the cell death that occurs in neurons during development of the nervous system. However, despite clinical and experimental data indicating Cu-mediated neurotoxicity in adult brain functions, 4, 11) the mechanisms of regulation of ROS and NO formation by Cu in the developing brain remain poorly understood.
The activity of superoxide dismutase (SOD), a key superoxide scavenging enzyme, is low in the developing brain and then becomes markedly increased along with a greater intensity of the aerobic enzymatic processes that occur during brain development.
2) Xanthine oxidase (XO) participates in the catabolism of purines in the cellular cytoplasm, while it has been implicated in such diverse pathological situations as organ ischemia, inflammation, and infection, due to its capability of generating both ROS and NO. 12, 13) The roles of ROS and NO in signaling have received interest in a variety of studies, and XO may serve as a source of ROS and NO intermediates in a host of cellular responses, including growth, survival, and apoptosis. 12, 14) Therefore, the main sources of superoxide anion production in the developing brain may be XO, reduced nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase, and prostaglandin metabolism including cyclooxygenase and lipoxygenase, though mitochondria are considered to be the main site of superoxide anion production in adult brains.
We initially isolated a unique compound from developing rat brain specimens and indentified it as b-citryl-L-glutamate (b-CG). 15) b-CG appears in high concentrations (300-600 mM) during the period characterized by growth and differentiation of neurons in developing animals, and then decreases with maturation. [16] [17] [18] [19] The stability constant obtained in our previous pH titration experiments showed that b-CG forms complexes with Cu, next in strength to Fe. 20) In the present study, we examined whether b-CG or its Cu-complex has SOD activity, and what kinds of effects those compounds have on XO. Our results showed that the [Cu(II)(b-CG)] complex has SOD activity and strongly inhibits XO. In addi- tion, we found that reduced glutathione (GSH) causes concentration-dependent decreases in the XO-inhibitory activities of the [Cu(II)(b-CG)] complex. GSH is known to be involved in the disposal of peroxides by brain cells and in the protection against ROS. 21) Thus, the [Cu(II)(b-CG)] complex may also play a role in the regulating redox state in the cytosol or mitochondria via SOD activity and inhibition of XO.
MATERIALS AND METHODS
Materials b-CG was synthesized as described previously. 15) Superoxide dismutase (SOD), deferoxamine mesylate and allopurinol were purchased from Sigma (MO, U.S.A.), while XO from buttermilk, bathocuproinedisulfonic acid disodium and N-1-naphthylethylenediamine dihydrochloride came from Wako Pure Chemicals (Osaka, Japan), and 2-thiobarbituric acid (TBA), GSH and xanthine sodium came from Nacalai Tesque (Kyoto, Japan). Gly-HisLys (GHK), 22) Cu chelating peptide, was obtained from Peptide Institute Inc. (Osaka, Japan).
Preparation of Metal Ion-Chelator Complexes
Metal ion-complexes with chelators were prepared according to the method described by Darr et al. Superoxide Quenching Activities Superoxide quenching activity was measured using a nitrite method as previously described, 24) with minor modifications. Hydroxylamine (0.4 mM), hypoxanthine (0.2 mM), XO (1.25 mU/ml), and the sample were incubated in 0.5 ml of potassium phosphate buffer (100 mM, pH 8.2) at 37°C for 30 min. Diazo dyeforming reagents [1 ml from 450 mg/ml of sulfanilic acid, and 7.5 mg/ml of N-1-naphthylethylenediamine in 25% (v/v) acetic acid] were added and absorption was measured at 550 nm.
XO Activity XO activity was determined in a manner similar to that described by Massey et al. 25) The conversion of xanthine to uric acid was followed at 295 nm. To a 0.5-ml reaction mixture containing 0.3 ml of sample solution and 0.1 ml of 0.5 mM xanthine, we added 0.1 ml of XO (1.25 mU/ml of 20.8 mM KH 2 PO 4 , 15.6 mM Na 2 B 4 O 7 buffer, pH 8.2). The reaction mixture was incubated for 10 min at room temperature and stopped by adding 1ml of 25% acetic acid.
Preparation of [Cu(I)(GSH)] Complex
The [Cu(I)-(GSH)] (Cu : GSHϭ1 : 2) complex was prepared by adding CuSO 4 to an anaerobic solution of GSH in 0.1 M phosphate buffer, pH 7.0, in N 2 gas, according to the method described by Ciriolo et al. 26) 
RESULTS

Effects of Metal Ion-(b-CG)
Complexes on SOD Activities Superoxides generated in vivo are known to be involved in the pathology of many diseases. Superoxide dismutases (SODs) scavenging superoxides are thought to be valuable in pharmaceutical treatments. Many low-molecular SOD-mimicking compounds including Cu, Mn and Fe complexes have been synthesized as functional models of native enzymes. 27 ) Therefore, we examined the ROS-scavenging activities of metal ion-(b-CG) complexes. Additionally, deferoxamine (desferrioxamine B), a hydroxamate-type siderophore isolated from streptomyces, has a high binding affinity for Fe(III), and can be used clinically to remove excess Fe from blood and tissues. 28) Deferoxamine and ethylenediaminetetraacetic acid (EDTA) were used as positive controls that can bind various metal ions containing Cu, Mn and Fe.
Metal ion-complexes with b-CG, EDTA, and deferoxamine were separately prepared by mixing Fe(II)O, Fe(III) 2 showed SOD activity at physiological pH levels, while [Cu(II)(EDTA)] also showed SOD activity. Furthermore, deferoxamine, in the Cu(II)-, Zn(II)-and Mn(IV)-complexes had strong SOD activities, whereas that in the Fe(II), Fe(III), and Ni(II) complexes had weak activities. The SOD activities of [Mn(IV)(deferoxamine)] complex and Cu(II) ion were similar to those in previous reports. 29, 30) Also, the Cu(II) complexes of various chelators including citrate, glutamate, GHK, and bathocuproine, a specific Cu chelator, showed concentration-dependent activities and their Superoxide dismutase (SOD) activities were measured using a nitrite method. 24) Hydroxylamine-o-sulphonic acid, XO, hypoxanthine, and the sample were incubated at 37°C for 30 min at pH 8.2, then the reactions were stopped with 25% acetic acid. Diazo dye-forming reagent (sulphanilic acid, N-1-naphthylethylenediamine) was added and absorption was measured at 550 nm. Fe-chelator-complex was used at 100 mM and the other complexes at 10 mM. Data are expressed as the meanϮS.E.M. (bar). * pϽ0.001 vs. control by Student's t test (nϭ3-4). ED 50 values for SOD activities are presented in Table 1 .
Effects of [Cu(II)(b-CG)]
Complexes on XO Activity XO is a key enzyme in the catabolism of purines, and has been shown to be a source of superoxide radicals in in vitro and in vivo experiments. 12, 31) In the present study, the effects of different metal ion-complexes of b-CG, deferoxamine, and EDTA on XO were examined ( Fig. 2A) . Among the metal ion-complexes tested, only the Cu(II) complexes of b-CG and deferoxamine showed strong inhibitory activities toward XO, whereas the metal ion complexes of EDTA had no effect. We also examined the effects of the Cu(II) complexes of citrate, glutamate, GHK, and bathocuproine on enzyme activities (Fig. 2B) . The Cu(II) complexes of citrate and glutamate showed inhibitory effects, while the Cu(II) complex of GHK showed a weak inhibitory effect, and the complex of bathocuproine had no effect. Moreover, free Cu(II) alone inhibited the activity of XO. The inhibitory effects of the Cu(II) complexes and free Cu(II) were concentration-dependent. However, the molar ratio of Cu to the chelator was varied or uncertain in the Cu(II) complexes. The concentrations (mmol/l per g-atom of Cu) necessary for inhibition at 50% of the control (IC 50 ) are presented in Table 1 . Using Lineweaver-Burk plots, the type of inhibition by [Cu(II)(b-CG)] and free Cu(II) were examined (Fig. 2C) , and both compounds showed competitive inhibition. All other Cu(II) complexes also acted as competitive inhibitors (data not shown).
The effects of incubation with EDTA were examined in order to determine if the inhibitory activities for XO originates from the Cu(II) complex itself or from free Cu(II) released from the complex. As shown in Fig. 3A , inhibition by free Cu(II) was greatly decreased when mixed with EDTA (0.8 mM), whereas inhibition by the [Cu(II)(b-CG)] complex was scarcely influenced by incubation with EDTA. The inhibitory effects of the Cu(II) complexes of citrate and deferoxamine decreased in an incubation time-dependent manner, though the effect of the [Cu(II)(Glu)] complex was only slightly inhibited by EDTA. Similar results were also obtained when incubated with GHK (1.2 mM) (Fig. 3B ) and bathocuproine (2 mM) (data not shown). These findings suggest that the [Cu(II)(b-CG)] complex itself, and not simply free Cu(II) released by the complex, exerts an inhibitory effect on XO.
Interaction between [Cu(II)(b-CG)] Complex and GSH
It has been proposed that reduced GSH is capable of chelating and detoxifying metals soon after they enter the cell. Since GSH may function as an intracellular Cu chelator, as well as a substrate for the removal of toxic oxygen species, 32) 1940
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Fig. 2. Effects of Cu-Chelator Complexes on XO Activities
XO Activity was measured by following the conversion of xanthine to uric acid at 295 nm. To a 0.5 ml reaction mixture containing 0.3 ml sample solution and 0.1 ml of 0.5 mM xaththine, were added 0.1 ml of XO. The reaction mixtures were incubated for 10 min at room temperature and were stopped by adding 1 ml of 25% acetic acid. Metal ion-chelator complexes were used at 10 mM and Cu(II) at 0. Ϫ1 to convert the observed absorbance changes. 25) The substrate concentration (S) was used as mM.
the effects of GSH were examined on the SOD and XO inhibitory activities of [Cu(II)(b-CG)]. As shown in Fig. 4A , GSH showed a slight inhibitory effect at a low concentration, whereas it had no effect at a high concentration. These effects were also found in regard to the SOD activity of CuSO 4 . Two possibilities to explain these findings are that GSH cannot slightly take away Cu ion from [Cu(II)(b-CG)], or GSH can take away Cu ion from that complex and the formed [Cu(I)(GSH)] complex itself has SOD activity. Therefore, a [Cu(I)(GSH)] (Cu : GSHϭ1 : 2) complex was prepared and its SOD activity was examined. As shown in Fig. 5A . Furthermore, it was difficult to determine whether the prepared [Cu(I)(GSH)] had direct XO inhibitory activity, because XO uses an O 2 molecule in a reaction medium for oxidation activity, while [Cu(I)(GSH)] are prepared in an anaerobic solution (N 2 gas).
26)
The effects of various reducing reagents, including dithiothreitol, 2-mercaptoethanol, cysteine and ascorbate, on the XO inhibitory activity of the [Cu(II)(b-CG)] complex were also examined (Fig. 5B) . Dithiothreitol had an abolishing effect, while 2-mercatoethanol and cysteine had only week effect, and ascorbate had none. The reducing reagent with a thiol residue was found to have an abolishing effect on the XO inhibitory activity of the [Cu(II)(b-CG)] complex. Moreover, GSH also showed abolishing effects on the XO inhibitory activities by [Cu(II)(deferoxamine)], [Cu(II)(citrate)], and [Cu(II)(Glu)] (Fig. 5C ). These findings support the notion that GSH interacts with the [Cu(II)(b-CG)] complex and can take away Cu ion from it. DISCUSSION b-CG is a unique compound initially isolated from developing brains, though its functional roles remain unclear. The tetra-carboxyl nature of b-CG, in which a b-carboxyl-residue of citrate and amino-residue of glutamate are linked with an amide bond, indicates that it may coordinate with metal ions. To evaluate that coordination, we performed pH titration experiments. The stability constant was calculated from pH titration data, which showed that b-CG forms relatively strong complexes with Fe(III), Cu(II), Fe(II) and Zn(II). After incubation of Cu(II) and Cu(II) complexes for 0-10 min with EDTA (A) or GHK (B), XO inhibitory activity was assayed. Metal ion-chelator complexes were used at 10 mM, Cu(II) was used at 1.0 mM, EDTA was used at 0.8 mM and GHK was used at 1.2 mM. Data are expressed as the meanϮS.E.M. (bar). Significant difference analyzed by one-way repeated measures ANOVA followed by Tukey-Kramer's correction ( * pϽ0.001, nϭ4).
Fig. 4. Effects of GSH on SOD Activity
SOD activity was measured using the same methods as described in Fig. 1 Superoxides generated in vivo are involved in the pathology of many diseases, thus, Cu/Zn superoxide dismutase and Mn dismutase, key superoxide scavenging enzymes, are thought to have potential uses in pharmaceutical treatments. Many low-molecular SOD-mimicking compounds, mainly Cu, Mn, and Fe complexes, have been synthesized as functional models of native enzymes.
27) Thus, we examined the ROS-scav- 29, 30) while the activities of deferoxamine, in the Cu(II)-, and Zn(II)-complex, and [Cu(II)(EDTA)] complexes are reported here for the first time. In addition, the Cu(II) complexes of various chelators including citrate, glutamate, and GHK were found to have SOD activities. It has been reported that SOD activity is low in the developing brain 2) and ROS and NO act as mediators of the cell death that occurs in neurons during development. Therefore, [Cu(II)(b-CG)] may play a role in regulation of ROS and NO levels via its SOD activity in the developing brain.
XO that participates in the catabolism of purines, is thought to primarily exist in the cellular cytoplasm, while it has also been implicated to have roles in diverse pathological situations due to its capability of generating both ROS and NO. 12, 13) The roles of ROS and NO in signaling including growth, survival, and apoptosis 12, 14) have received attention in a variety of studies, and cytoplasmic XO is considered to serve as a source of ROS and NO intermediates in the developing brain. In the present study, we found that the Cu(II) complexes of b-CG and deferoxamine strongly inhibited the activity of XO. To the best of our knowledge, the present results are the first to show inhibitory activity by low molecular weight Cu-complexes. The Cu(II) complexes of citrate and glutamate also showed inhibitory effects, while the Cu(II) complex of GHK showed only a weak inhibitory effect, and the complex of EDTA had no effect. It is interesting to note that the [Cu(II)(EDTA)] complex showed no XO inhibitory activities in the spite of its SOD activities. Although, the mechanism of that finding is unclear at the present time, it is possible that EDTA has strong stability constants for Cu as compared to those of b-CG, citrate, glutamate and GHK, which have both SOD activity and XO inhibitory activity. EDTA could occupy the 6 coordination sites in the [Cu(II)(EDTA)] complex, as it is large enough to surround the Cu atom, resulting in formation of a stable hexadentate structure.
Active XO, a molybdo-flavoenzyme, is composed of a homodimeric complex. 13) During oxidation by XO, a substrate is oxidized at the molybdenum center, thus forming R-OH, and the reducing equivalents are passed to flavin, which is reoxidized by molecular oxygen. The Fe/S centers are thought to mediate the transfer of electrons between the molybdenum and flavin cofactors, and also serve as electron sinks, storing reducing equivalents during catalysis. Although there is no direct evidence to support that model, we suspect that [Cu(II)(b-CG)] and free Cu(II) may interfere with the transfer of electrons between the molybdenum and flavin cofactors, because Cu is able to participate in single-electron exchange reactions.
Under physiological conditions, Cu enters cells by the activity of a high affinity transporter. Initially, intracellular Cu was thought to loosely bind to small molecules such as histidine and GSH (1-10 mM), with the resultant pool considered likely to form the basis of chelatable Cu found within cells. 33) On the other hand, GSH is deeply involved in the disposal of peroxides by neuronal and neuroglial cells, and as well as protection against ROS. Astroglial cells play a prominent role in GSH metabolism and defense against ROS in the mature brain, e.g., they protect other neural cell types against the toxicity of various compounds by supplying GSH precursors to neighboring cells. 21) However, it is notable that astroglial cells develop relatively late in the developing brain after completion of neuronal cell multiplication. 34) Neuronal cells appear to contain lower levels of GSH than astroglial cells in the developing brain. 21) On the other hand, the concentration of b-CG (300-600 mM) is high in the developing brain during the period characterized by neuronal cell growth. 17, 18) The present findings revealed that b-CG binds to Cu and the resulting [Cu(II)(b-CG)] complex has strong antioxidant activities similar to those of GSH. In addition, the [Cu(II)(b-CG)] complex demonstrated SOD activity and strong inhibition of XO. Therefore, it is reasonable that b-CG forms a complex with Cu in the cytosol or mitochondria, with the resulting [Cu(II)(b-CG)] complex participating there in regulation of the redox state.
